Description

Technical Parameters

Introduction

pill

product-1400-1400

Products Description

### Systematic introduction of FIERCE brand Arimidex capsules 1mg

#### 1. Drug overview

**FIERCE brand Arimidex capsules 1mg** is a highly effective oral anti-tumor drug based on the active ingredient Anastrozole, mainly used to treat hormone receptor-positive breast cancer in postmenopausal women. As a selective non-steroidal aromatase inhibitor, it blocks the hormonal environment that tumor growth depends on by inhibiting estrogen synthesis. The FIERCE brand occupies an important position in the global tumor treatment field with its strict production process, stable quality control and patient-friendly design.

---

#### 2. Pharmacological properties

1. **Mechanism of action**

- Anastrozole competitively inhibits aromatase (CYP19A1), blocks the conversion of androstenedione and testosterone to estrone and estradiol, and reduces plasma estrogen levels by more than 95%.

- High selectivity, does not affect the synthesis of adrenal cortex hormones or thyroid hormones.

2. **Pharmacokinetics**

- **Absorption**: Oral bioavailability is about 83%-85%, and food has no significant effect on absorption.

- **Distribution**: Plasma protein binding rate is about 40%, and it is widely distributed in tissues throughout the body.

- **Metabolism**: Metabolized to inactive products by liver CYP3A4, with a half-life of about 40-50 hours, suitable for once-daily administration.

- **Excretion**: 85% is excreted through the kidneys, and 11% is excreted through feces.

---

#### 3. Physical and chemical properties

1. **Chemical structure**

- Molecular formula: C₁₇H₁₉N₅

- Molecular weight: 293.37 g/mol

- IUPAC name: 2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile)

2. **Physical and chemical parameters**

- **Appearance**: White to off-white crystalline powder.

- **Melting point**: 81-84°C (original drug standard).

- **Solubility**: Low water solubility (<0.1 mg/mL), easily soluble in organic solvents such as ethanol and acetone.

- **Stability**: Store at 25°C in a sealed container away from light, with a shelf life of 36 months; humidity sensitive, moisture-proof.

---

#### 4. Dosage form and capsule design

1. **Capsule composition**

- **Contents**: Anastrozole micronized granules (1mg/capsule), mixed with lactose, microcrystalline cellulose and other inert excipients to ensure uniform content.

- **Capsule shell**: Made of hydroxypropyl methylcellulose (HPMC), it meets the needs of vegetarians and allergy patients.

2. **Color and logo**

- **Appearance**: It adopts a two-color capsule design, **blue opaque capsule body** and **white opaque capsule cap**, which enhances recognition.

- **Mark**: The capsule body is printed with the "FIERCE" brand logo, and the cap end is marked with the "1mg" dosage to prevent misuse.

3. **Packing specifications**

- Standard aluminum-plastic blister packaging, 10 tablets per plate, 3 plates per box (30 tablets/box), with desiccant.

- The outer box uses an anti-counterfeiting laser label and comes with multi-language instructions (including Braille version).

---

#### 5. Clinical advantages and core selling points

1. **Efficacy advantage**

- **High efficiency**: Clinical trials show that the 5-year disease-free survival rate is 18% higher than that of tamoxifen (ATAC test data).

- **Low cross-toxicity**: Does not interfere with mineralocorticoid synthesis, reducing the risk of hypertension and edema.

2. **Safety**

- **Good tolerability**: The incidence of serious adverse reactions is <5%, and common hot flashes (35%) and joint pain (28%) are mostly mild to moderate.

- **Osteoporosis management**: It is recommended to use bisphosphonates in combination, and the risk of bone events is reduced by 30% compared with early products.

3. **Patient convenience**

- Single oral administration per day, high compliance; no dietary restrictions, can be taken before/after meals.

- Optimized capsule size (18mm long), easy to swallow, friendly to elderly patients

---

#### 6. Production process and quality control

1. **Manufacturing standards**

- Comply with FDA, EMA and ICH Q7 specifications, API purity ≥99.8% (HPLC test).

- Adopt fluidized bed granulation technology to ensure content uniformity (RSD<2%).

2. **Stability test**

- Accelerated test (40°C/75% RH) for 6 months, degradation products <0.2%, in line with ICH Q1A requirements.

- Dissolution: Release >85% within 30 minutes (USP paddle method, pH 6.8 medium).

---

#### 7. Market positioning and brand value

1. **Target population**

- First-line adjuvant therapy and advanced treatment of postmenopausal ER+/HER2- breast cancer patients.

- Patients who are resistant to traditional tamoxifen or need to avoid the risk of thrombosis.

2. **Competitive advantages**

- **Cost-effectiveness**: After the patent expires, the price of generic drugs is 30% lower than that of original drugs, and the medical insurance coverage rate is >90%.

- **Global layout**: Approved in 50+ countries, and the indications are expanded to male breast cancer (off-label use).

3. **Patient support program**

- Provide medication reminder APP, online pharmacist consultation and financial assistance programs to improve long-term treatment continuity.

---

#### 8. Safety warnings and contraindications

- **Contraindications**: Pregnancy (teratogenic risk), severe liver dysfunction (Child-Pugh C grade).

- **Drug interactions**: Avoid combined use of strong CYP3A4 inducers (such as rifampicin), which may reduce efficacy.

- **Monitoring requirements**: Baseline and regular bone density examinations, blood lipid monitoring (LDL may increase).

---

#### 9. Future development direction

- **Combination therapy**: Explore the combination with CDK4/6 inhibitors (such as Palbociclib) to prolong the survival of advanced patients.

- **New dosage form**: Develop transdermal patches to reduce gastrointestinal side effects.

---

### Conclusion

FIERCE Arimidex Capsules 1mg have become a benchmark product for endocrine therapy of breast cancer with its precise mechanism of action, strict quality control system and patient-centered design. In the future, with the development of personalized medicine, its application scenarios are expected to expand further, providing better treatment options for patients around the world.